Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL428496 (Wortmannin) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
protein kinase, DNA-activated, catalytic subunit/DNA-dependent protein kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3142] [GtoPdb: 2800] [UniProtKB: P78527] | ||||||||
GtoPdb | - | - | 6.92 | pKi | 120 | nM | Ki | Bioorg Med Chem Lett (2012) 22: 5352-9 [PMID:22835870] |
ChEMBL | Binding affinity for DNA dependent protein kinase isolated from HeLa cells; Range is 20-120 | B | 6.92 | pKi | 120 | nM | Ki | J Med Chem (2005) 48: 569-585 [PMID:15658870] |
ChEMBL | Inhibition of DNA-PK isolated from human HeLa cell extract | B | 6.92 | pKi | 120 | nM | Ki | Bioorg Med Chem Lett (2012) 22: 5352-5359 [PMID:22835870] |
Myosin light chain kinase, smooth muscle in Chicken (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3062] [UniProtKB: P11799] | ||||||||
ChEMBL | Inhibition of chicken SmMLCK expressed in Escherichia coli | B | 6.59 | pIC50 | 260 | nM | IC50 | Biochem J (2000) 351: 95-105 [PMID:10998351] |
myosin light chain kinase/Myosin light chain kinase, smooth muscle in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2428] [GtoPdb: 1552] [UniProtKB: Q15746] | ||||||||
ChEMBL | Inhibition of SmMLCK in the presence of 50uM ATP | B | 5.3 | pIC50 | 5000 | nM | IC50 | Biochem J (2007) 408: 297-315 [PMID:17850214] |
ChEMBL | Inhibition of Smooth muscle myosin light chain kinase (mMLCK) | B | 5.72 | pIC50 | 1900 | nM | IC50 | J Med Chem (2003) 46: 1478-1483 [PMID:12672248] |
ChEMBL | Inhibition of MLCK by HTRF assay | B | 6.77 | pIC50 | 170 | nM | IC50 | Bioorg Med Chem (2011) 19: 429-439 [PMID:21130659] |
phosphatidylinositol 3-kinase catalytic subunit type 3/Phosphatidylinositol 3-kinase catalytic subunit type 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075165] [GtoPdb: 2152] [UniProtKB: Q8NEB9] | ||||||||
ChEMBL | Inhibition of VPS34 (unknown origin) | B | 8.38 | pIC50 | 4.2 | nM | IC50 | Eur J Med Chem (2022) 244: 114846-114846 [PMID:36283182] |
phosphoinositide-3-kinase regulatory subunit 1/phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/PI3-kinase p110-alpha/p85-alpha in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111367] [GtoPdb: 2503, 2153] [UniProtKB: P27986, P42336] | ||||||||
GtoPdb | - | - | 8.27 | pKd | 5.4 | nM | Kd | J Med Chem (2018) 61: 10463-10472 [PMID:30380865] |
GtoPdb | - | - | 6.92 | pKi | 120 | nM | Ki | J Med Chem (2005) 48: 569-85 [PMID:15658870] |
ChEMBL | Inhibition of PI3K p110alpha/p85alpha (unknown origin) by ADP-Glo assay | B | 5.79 | pIC50 | 1610 | nM | IC50 | Eur J Med Chem (2013) 60: 187-198 [PMID:23291120] |
ChEMBL | Inhibition of human recombinant P110alpha/p85alpha using phosphatidyl inositol as substrate after 1 hr by ADP-Glo Kinase assay | B | 7.92 | pIC50 | 11.9 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 6919-6922 [PMID:23040731] |
ChEMBL | Inhibition of human full-length recombinant p110alpha/p85alpha co-expressed in baculovirus expression system using PIP2:PS lipid as substrate incubated for 1 hr in presence of ATP by ADP-Glo assay | B | 8 | pIC50 | 10.1 | nM | IC50 | J Med Chem (2018) 61: 1552-1575 [PMID:29360358] |
ChEMBL | Inhibition of PI3 kinase p110alpha/p85-alpha complex | B | 8.92 | pIC50 | 1.2 | nM | IC50 | Bioorg Med Chem Lett (2006) 16: 2518-2521 [PMID:16464575] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/PI3-kinase p110-alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4005] [GtoPdb: 2153] [UniProtKB: P42336] | ||||||||
ChEMBL | Binding affinity to human PI3Kalpha after 1 hr by KINOMEscan assay | B | 8.27 | pKd | 5.4 | nM | Kd | J Med Chem (2018) 61: 10463-10472 [PMID:30380865] |
GtoPdb | - | - | 8.27 | pKd | 5.4 | nM | Kd | J Med Chem (2018) 61: 10463-10472 [PMID:30380865] |
GtoPdb | - | - | 6.92 | pKi | 120 | nM | Ki | J Med Chem (2005) 48: 569-85 [PMID:15658870] |
ChEMBL | Binding affinity for Phosphatidylinositol 3-kinase isolated from HeLa cells; Range is 20-120 | B | 6.92 | pKi | 120 | nM | Ki | J Med Chem (2005) 48: 569-585 [PMID:15658870] |
ChEMBL | Inhibition of PI3K p110alpha (unknown origin) using PIP2 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr | B | 6 | pIC50 | >=1000 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 2510-2514 [PMID:28462836] |
ChEMBL | Inhibition of PI3K by fluorescence energy transfer assay | B | 7.75 | pIC50 | 17.6 | nM | IC50 | J Med Chem (2008) 51: 4699-4707 [PMID:18630894] |
ChEMBL | Inhibition of human p110alpha PI3K fragment by AlphaScreen assay | B | 7.89 | pIC50 | 13 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 829-835 [PMID:21169017] |
ChEMBL | Inhibition of human PI3Kalpha expressed in Sf9 cells by fluorescent polarization assay | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2010) 53: 8523-8533 [PMID:21121631] |
ChEMBL | Inhibition of PI3Kalpha (unknown origin) by fluorescent polarization assay | B | 7.92 | pIC50 | 12 | nM | IC50 | Medchemcomm (2012) 3: 1337-1355 |
ChEMBL | Inhibition of PI3 kinase | B | 7.92 | pIC50 | 12 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4223-4227 [PMID:19523825] |
ChEMBL | Inhibition of human PI3Kalpha | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (2006) 49: 3857-3871 [PMID:16789742] |
ChEMBL | Inhibition of PI3Kalpha | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (2012) 55: 8559-8581 [PMID:22924688] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta/PI3-kinase p110-beta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3145] [GtoPdb: 2154] [UniProtKB: P42338] | ||||||||
ChEMBL | Binding affinity to human PI3Kbeta after 1 hr by KINOMEscan assay | B | 8.12 | pKd | 7.6 | nM | Kd | J Med Chem (2018) 61: 10463-10472 [PMID:30380865] |
GtoPdb | - | - | 8.12 | pKd | 7.6 | nM | Kd | J Med Chem (2018) 61: 10463-10472 [PMID:30380865] |
ChEMBL | Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay | B | 7.82 | pIC50 | 15 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 829-835 [PMID:21169017] |
ChEMBL | Inhibition of PI3Kbeta | B | 7.85 | pIC50 | 14 | nM | IC50 | J Med Chem (2012) 55: 8559-8581 [PMID:22924688] |
ChEMBL | Inhibition of human PI3Kbeta | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2006) 49: 3857-3871 [PMID:16789742] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta/PI3-kinase p110-delta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3130] [GtoPdb: 2155] [UniProtKB: O00329] | ||||||||
ChEMBL | Binding affinity to human PI3Kdelta after 1 hr by KINOMEscan assay | B | 8.26 | pKd | 5.5 | nM | Kd | J Med Chem (2018) 61: 10463-10472 [PMID:30380865] |
GtoPdb | - | - | 8.26 | pKd | 5.5 | nM | Kd | J Med Chem (2018) 61: 10463-10472 [PMID:30380865] |
ChEMBL | Inhibition of human PI3Kdelta | B | 8.05 | pIC50 | 9 | nM | IC50 | J Med Chem (2006) 49: 3857-3871 [PMID:16789742] |
ChEMBL | Inhibition of PI3Kdelta | B | 8.05 | pIC50 | 9 | nM | IC50 | J Med Chem (2012) 55: 8559-8581 [PMID:22924688] |
ChEMBL | Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay | B | 8.4 | pIC50 | 4 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 829-835 [PMID:21169017] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma/PI3-kinase p110-gamma subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3267] [GtoPdb: 2156] [UniProtKB: P48736] | ||||||||
GtoPdb | - | - | 7.82 | pKd | 15 | nM | Kd | J Med Chem (2018) 61: 10463-10472 [PMID:30380865] |
ChEMBL | Binding affinity to human PI3Kgamma after 1 hr by KINOMEscan assay | B | 7.82 | pKd | 15 | nM | Kd | J Med Chem (2018) 61: 10463-10472 [PMID:30380865] |
ChEMBL | Inhibition of PI3Kgamma (unknown origin) assessed as decrease in fluorescence intensity using phosphorylated substrate | B | 4.26 | pIC50 | 55000 | nM | IC50 | Eur J Med Chem (2014) 84: 454-465 [PMID:25050878] |
ChEMBL | Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay | B | 7.05 | pIC50 | 89 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 829-835 [PMID:21169017] |
ChEMBL | Inhibition of PI3Kgamma assessed as inhibition of 32P-PIP3 formation | B | 7.72 | pIC50 | 19 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 756-760 [PMID:17095227] |
ChEMBL | Inhibition of human PI3Kgamma | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2006) 49: 3857-3871 [PMID:16789742] |
ChEMBL | Inhibition of PI3Kgamma | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2012) 55: 8559-8581 [PMID:22924688] |
phosphatidylinositol 4-kinase alpha/PI4-kinase alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3667] [GtoPdb: 2148] [UniProtKB: P42356] | ||||||||
ChEMBL | Inhibition of PI4KA catalytic domain (unknown origin) assessed as enzyme residual activity incubated for 60 mins using ATP as substrate by ATP-Glo luminescent assay | B | 6.55 | pIC50 | 280 | nM | IC50 | Bioorg Med Chem Lett (2022) 76: 129010-129010 [PMID:36184029] |
GtoPdb | - | - | 6.8 | pIC50 | - | - | - |
J Biol Chem (1997) 272: 4384-90 [PMID:9020160]; Biochim Biophys Acta (1999) 1437: 341-56 [PMID:10101268] |
phosphatidylinositol 4-kinase beta/PI4-kinase beta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3268] [GtoPdb: 2149] [UniProtKB: Q9UBF8] | ||||||||
ChEMBL | Inhibition of PI4KB catalytic domain (unknown origin) assessed as enzyme residual activity incubated for 60 mins using ATP as substrate by ATP-Glo luminescent assay | B | 6.36 | pIC50 | 440 | nM | IC50 | Bioorg Med Chem Lett (2022) 76: 129010-129010 [PMID:36184029] |
GtoPdb | - | - | 6.8 | pIC50 | - | - | - |
J Biol Chem (1997) 272: 4384-90 [PMID:9020160]; Biochim Biophys Acta (1999) 1437: 341-56 [PMID:10101268] |
phosphatidylinositol 4-kinase type 2 alpha/PI4-kinase type II in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2251] [GtoPdb: 2498] [UniProtKB: Q9BTU6] | ||||||||
ChEMBL | Inhibition of PI4K2A catalytic domain (unknown origin) assessed as enzyme residual activity incubated for 60 mins using ATP as substrate by ATP-Glo luminescent assay | B | 4.52 | pIC50 | >30000 | nM | IC50 | Bioorg Med Chem Lett (2022) 76: 129010-129010 [PMID:36184029] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay | F | 5 | pIC50 | 10000 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay | F | 5 | pIC50 | 10000 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
mechanistic target of rapamycin kinase/Serine/threonine-protein kinase mTOR in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2842] [GtoPdb: 2109] [UniProtKB: P42345] | ||||||||
ChEMBL | Binding affinity to human mTOR after 1 hr by KINOMEscan assay | B | 5.04 | pKd | 9200 | nM | Kd | J Med Chem (2018) 61: 10463-10472 [PMID:30380865] |
GtoPdb | - | - | 5.04 | pKd | 9200 | nM | Kd | J Med Chem (2018) 61: 10463-10472 [PMID:30380865] |
ChEMBL | Inhibitory activity against MTOR | B | 7.4 | pIC50 | 40 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 4799-4802 [PMID:16143526] |
mechanistic target of rapamycin kinase/Serine/threonine-protein kinase mTOR in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075134] [GtoPdb: 2109] [UniProtKB: P42346] | ||||||||
ChEMBL | Inhibition of mTOR in rat brain by [3H]-thymidine incorporation based immunoblot assay | B | 6.52 | pIC50 | 300 | nM | IC50 | Eur J Med Chem (2020) 208: 112820-112820 [PMID:32966896] |
polo like kinase 1/Serine/threonine-protein kinase PLK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3024] [GtoPdb: 2168] [UniProtKB: P53350] | ||||||||
ChEMBL | Inhibition of PLK1 in the presence of 5uM ATP | B | 5.89 | pIC50 | 1300 | nM | IC50 | Biochem J (2007) 408: 297-315 [PMID:17850214] |
ChEMBL | Inhibition of GST-tagged Plk1 using recombinant protein X as a substrate containing threonine residues | B | 7.62 | pIC50 | 24 | nM | IC50 | J Med Chem (2012) 55: 6243-6262 [PMID:22621397] |
ChEMBL | Inhibition of AX-7503 binding to recombinant Plk1 by Western blot | B | 8.24 | pIC50 | 5.8 | nM | IC50 | J Biol Chem (2007) 282: 2505-2511 [PMID:17135248] |
polo like kinase 3/Serine/threonine-protein kinase PLK3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4897] [GtoPdb: 2170] [UniProtKB: Q9H4B4] | ||||||||
ChEMBL | Inhibition of Plk3 in human A549 cells assessed as casein substrate phosphorylation by Western blot | B | 6.66 | pIC50 | 220 | nM | IC50 | J Biol Chem (2007) 282: 2505-2511 [PMID:17135248] |
ChEMBL | Inhibition of AX-7503 binding to recombinant Plk3 expressed in HeLa cells by Western blot | B | 7.31 | pIC50 | 49 | nM | IC50 | J Biol Chem (2007) 282: 2505-2511 [PMID:17135248] |
ChEMBL | Inhibition of recombinant Plk3 assessed as casein substrate phosphorylation | B | 7.32 | pIC50 | 48 | nM | IC50 | J Biol Chem (2007) 282: 2505-2511 [PMID:17135248] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]